Search

everythinglearnresearchcommunity

for

Search:↓

Most people who volunteered for a health study had medical issues, showing the need for careful screening before trials.

CTE can distort results in hair growth trials, so exclude it carefully.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Regenerative medicine is effective and safe for treating vitiligo.

Combining low-level light therapy with minoxidil helps hair regrowth better than using minoxidil alone, especially early on.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

New methods improve how we test hair growth treatments, but challenges like slow hair changes and high costs remain.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Biotin supplements may improve hair and nail growth in people with certain deficiencies or conditions, but there's not enough evidence to recommend it for healthy individuals.

Platelet-Rich Plasma (PRP) may increase hair density and thickness in Androgenetic Alopecia, but it's not significantly better than a placebo.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

WAA-QOL measures impact of hair loss on women's well-being.

Higher free testosterone levels can increase bone density and decrease body fat but may raise the risk of prostate cancer, hair loss, and benign prostate enlargement.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Bimatoprost is effective for growing longer, thicker, and darker eyelashes.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Delaying hair loss treatment reduces its effectiveness.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Sublingual minoxidil helped regrow hair in a person with congenital triangular alopecia.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

A hormone affects hair growth, certain molecules may prevent skin damage, a skin disease is linked to immune cells, glycerol helps skin hydration, and psoriasis treatment trials need improvement.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Using more than 5% minoxidil can help hair growth more, but results vary and side effects may increase.